{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:01:49Z","timestamp":1790377309949,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jns.2026.126182","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:19:06Z","timestamp":1790003946000},"page":"126182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["No evidence of cerebral microangiopathy in hereditary transthyretin amyloidosis: An MRI case-control study from an Italian Center"],"prefix":"10.1016","volume":"491","author":[{"given":"Alessandro","family":"Salvalaggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Librizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Verriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Tagliapietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eros","family":"Cerantola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Tierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Fabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Obici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Briani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jns.2026.126182_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2026.126182_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14103481","article-title":"Pharmacological management of transthyretin amyloid cardiomyopathy: where we are and where we are going","volume":"14","author":"De Michieli","year":"2025","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.jns.2026.126182_bb0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.26845","article-title":"Disease-modifying drugs extend survival in hereditary transthyretin amyloid polyneuropathy","volume":"95","author":"Ueda","year":"2024","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2026.126182_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","article-title":"CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings","volume":"86","author":"Maia","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2026.126182_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-022-02501-9","article-title":"Neuropathology of central nervous system involvement in TTR amyloidosis","volume":"145","author":"Taipa","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.jns.2026.126182_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/13506129.2024.2435573","article-title":"Pathogenesis, manifestations, diagnosis, and management of CNS complications in hereditary ATTR amyloidosis","volume":"32","author":"Sekijima","year":"2025","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.jns.2026.126182_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70427","article-title":"Early detection of central nervous system involvement in ATTRv using multimodal MRI and cognitive assessments","volume":"33","author":"de Fran\u00e7a Nunes","year":"2026","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2026.126182_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaneurol.2023.5762","article-title":"Origin of transthyretin in cerebral amyloid angiopathy","volume":"81","author":"Nomura","year":"2024","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.jns.2026.126182_bb0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2026.126182_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/13506129.2024.2391842","article-title":"Brain MRI in patients with V30M hereditary transthyretin amyloidosis","volume":"31","author":"Sousa","year":"2024","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.jns.2026.126182_bb0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00415-025-13120-1","article-title":"Cognitive manifestations and brain integrity in hereditary transthyretin amyloidosis: a systematic review","volume":"272","author":"Senem","year":"2025","journal-title":"J. Neurol."},{"issue":"24","key":"10.1016\/j.jns.2026.126182_bb0060","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.0000000000012965","article-title":"CNS involvement in hereditary transthyretin amyloidosis","volume":"97","author":"Sousa","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2026.126182_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/jns.70088","article-title":"Impact of high-dose tafamidis on hereditary ATTR (ATTRv) amyloidosis with central nervous system involvement: two case reports with clinical, radiological and cerebrospinal fluid follow up","volume":"30","author":"Zhang","year":"2025","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"2","key":"10.1016\/j.jns.2026.126182_bb0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40120-020-00217-0","article-title":"A narrative review of the role of transthyretin in health and disease","volume":"9","author":"Liz","year":"2020","journal-title":"Neurol. Ther."},{"issue":"1","key":"10.1016\/j.jns.2026.126182_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2536755","article-title":"Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis","volume":"57","author":"Gertz","year":"2025","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.jns.2026.126182_bb0080","first-page":"1","article-title":"Central nervous system manifestations associated with hereditary transthyretin amyloidosis: a narrative review","volume":"84","author":"Costa","year":"2026","journal-title":"Arq. Neuropsiquiatr."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:58Z","timestamp":1790375998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26004648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":16,"alternative-id":["S0022510X26004648"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126182","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No evidence of cerebral microangiopathy in hereditary transthyretin amyloidosis: An MRI case-control study from an Italian Center","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126182"}}